Your shopping cart is currently empty

VER-50589 is a potent HSP90 inhibitor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $35 | In Stock | In Stock | |
| 5 mg | $98 | In Stock | In Stock | |
| 10 mg | $162 | In Stock | In Stock | |
| 25 mg | $278 | In Stock | In Stock | |
| 50 mg | $426 | In Stock | In Stock | |
| 100 mg | $619 | In Stock | In Stock | |
| 200 mg | $875 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $98 | In Stock | In Stock |
| Description | VER-50589 is a potent HSP90 inhibitor. |
| Targets&IC50 | HSP90 β:21 nM |
| In vitro | The induction of HSP72 and HSP27 by VER-50589 was accompanied by depletion of client proteins (including C-RAF, B-RAF, and survivin) and the protein arginine methyltransferase PRMT5, which further led to cell cycle arrest and apoptosis.VER-50589 inhibited the intrinsic ATPase activity of recombinant yeast Hsp90 with an IC50 of 143 nM, and inhibited the intrinsic ATPase activity of recombinant yeast Hsp90 in vitro with an IC50 of 143 nM. and produced antiproliferative activity in a panel of human cancer cell lines and non-tumorigenic cells in vitro. |
| In vivo | The induction of HSP72 and HSP27 by VER-50589 was accompanied by depletion of client proteins (including C-RAF, B-RAF, and survivin) and the protein arginine methyltransferase PRMT5, which further led to cell cycle arrest and apoptosis.VER-50589 inhibited the intrinsic ATPase activity of recombinant yeast Hsp90 with an IC50 of 143 nM, and inhibited the intrinsic ATPase activity of recombinant yeast Hsp90 in vitro with an IC50 of 143 nM. and produced antiproliferative activity in a panel of human cancer cell lines and non-tumorigenic cells in vitro. |
| Kinase Assay | Fluorescence Polarization Assay: Binding of HSP90 inhibitors to human full-length recombinant HSP90β is determined by a competitive binding fluorescence polarization assay, using a fluorescent pyrazole resorcinol probe. |
| Cell Research | Antiproliferative effects are measured using the sulforhodamine B assay. HUVEC sensitivity is determined by an alkaline phosphatase method.(Only for Reference) |
| Synonyms | VER50589 |
| Molecular Weight | 388.8 |
| Formula | C19H17ClN2O5 |
| Cas No. | 747413-08-7 |
| Smiles | CCNC(=O)c1noc(c1-c1ccc(OC)cc1)-c1cc(Cl)c(O)cc1O |
| Relative Density. | 1.360 g/cm3 (Predicted) |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 71 mg/mL (182.61 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 71 mg/mL (182.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.